Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
8.19
+0.20 (2.50%)
Oct 15, 2026, 4:00 PM EDT - Market closed
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $200.7 million as of October 15, 2026. It is the 20,755th most valuable company in the world and the 3,580th biggest in the United States. Its market cap has decreased by 38.04% in one year.
Market Cap
200.70M
Enterprise Value
19.30M
1-Year Change
-38.04%
Global Rank
Country Rank
#3,580 United States
Category
ChartMarket Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $200.70M, a decrease of -95.14%. That is a compound annual growth rate of -43.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 200.70M | -69.31% |
| Dec 31, 2025 | 653.89M | 249.70% |
| Dec 31, 2024 | 186.98M | -61.73% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
| Jun 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lexeo Therapeutics | 218.23M |
| Pyxis Oncology | 216.81M |
| Camp4 Therapeutics | 213.36M |
| MacroGenics | 209.57M |
| Evommune | 207.95M |
| ProQR Therapeutics | 207.45M |
| Alector | 203.77M |
| Cartesian Therapeutics | 193.94M |